(Reuters) - Swiss drugmaker Novartis on Friday said it had sued the U.S. government in an attempt to halt the Medicare drug-price negotiation program, which includes its top-selling heart-failure ...
Anglo-Swedish group is latest to challenge Medicare’s new power to negotiate prices for a limited number of medicines ...
(Reuters) -AstraZeneca said on Friday it has sued the U.S. government to block parts of a program that gives the Medicare health insurance plan the power to negotiate lower drug prices. The ...
(Reuters) - Swiss drugmaker Novartis on Friday said it had sued the U.S. government in an attempt to halt the Medicare drug-price negotiation program, which includes its top-selling heart-failure ...
We’ll send you a myFT Daily Digest email rounding up the latest AstraZeneca PLC news every morning. AstraZeneca has become the latest large pharmaceutical company to sue the US over a law that ...
Sept 1 (Reuters) - Swiss drugmaker Novartis (NOVN.S) on Friday said it had sued the U.S. government in an attempt to halt the Medicare drug-price negotiation program, which includes its top ...
Sept 1 (Reuters) - Swiss drugmaker Novartis on Friday said it had sued the U.S. government in an attempt to halt the Medicare drug-price negotiation program, which includes its top-selling heart ...
(Reuters) - Swiss drugmaker Novartis on Friday said it had sued the U.S. government in an attempt to halt the Medicare drug-price negotiation program, which includes its top-selling heart-failure ...
(Reuters) - Swiss drugmaker Novartis on Friday said it had sued the U.S. government in an attempt to halt the Medicare drug-price negotiation program, which includes its top-selling heart-failure ...
Sept 1 (Reuters) - Swiss drugmaker Novartis NOVN.S on Friday said it had sued the U.S. government in an attempt to halt the Medicare drug-price negotiation program, which includes its top-selling ...
(Reuters) - Swiss drugmaker Novartis on Friday said it had sued the U.S. government in an attempt to halt the Medicare drug-price negotiation program, which includes its top-selling heart-failure ...
